Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188,027 | 186,579 | 240,089 | 50,668 | 235,807 |
| Marketable Securities | 187,503 | 262,998 | 260,464 | N/A | 317,679 |
| Receivables | 8,656 | 43,830 | 46,139 | N/A | 352,449 |
| Inventories | N/A | N/A | N/A | N/A | 106,561 |
| Other current assets | 22,278 | 24,669 | 19,331 | 11,972 | 61,485 |
| TOTAL | $434,118 | $544,476 | $586,968 | $80,550 | $1,174,341 |
| Non-Current Assets | |||||
| PPE Net | 17,277 | 17,494 | 17,512 | 17,423 | 15,727 |
| Intangibles | 19,790 | 19,790 | 19,790 | 19,790 | 75,112 |
| Other Non-Current Assets | 35,551 | 36,761 | 37,513 | 17,883 | 121,069 |
| TOTAL | $72,618 | $74,045 | $74,815 | $55,096 | $211,908 |
| Total Assets | $506,736 | $618,521 | $661,783 | $135,646 | $1,386,249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,039 | 14,456 | 10,703 | 4,731 | 64,149 |
| Accrued Expenses | 35,393 | 38,002 | 44,106 | 23,704 | 545,307 |
| Other current liabilities | 40,415 | 61,548 | 35,212 | N/A | 62,500 |
| TOTAL | $87,847 | $114,006 | $90,021 | $28,435 | $671,956 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 764,983 |
| Other Non-Current Liabilities | 31,634 | 32,257 | 32,991 | 6,995 | 754,868 |
| TOTAL | $31,634 | $32,257 | $32,991 | $6,995 | $1,519,851 |
| Total Liabilities | $119,481 | $146,263 | $123,012 | $35,430 | $2,191,807 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,317 | 68,225 | 68,212 | 68,161 | 71,495 |
| Common Shares | 617,510 | 616,246 | 615,742 | N/A | 2,181,398 |
| Retained earnings | -251,962 | -161,616 | -91,124 | N/A | -3,143,541 |
| Other shareholders' equity | 20 | 166 | 284 | 100,216 | -10,436 |
| TOTAL | $387,255 | $472,258 | $538,771 | $100,216 | $-805,558 |
| Total Liabilities And Equity | $506,736 | $618,521 | $661,783 | $135,646 | $1,386,249 |